Abstract

Alzheimer's disease (AD) represents a major public health problem and it is therefore crucial that modifiable risk factors be known prior to onset of dementia in late-life. The "Australian National University - Alzheimer's Disease Risk Index" (ANU-ADRI) is one of the potential tools for primary prevention of the disease.ObjectiveThe aim of this study was to devise an adapted version of the ANU-ADRI for use in Brazil.MethodsThe instrument was translated from its original language of English into Portuguese and then back-translated into English by bilingual translators. It was subsequently reviewed and evaluated as to the degree of translation issues and equivalence. In this study, the ANU-ADRI was applied using individual (face-to-face) interviews in a public hospital, unlike the original version which is applied online by self-report. The final version (pretest) was evaluated in a sample of 10 participants with a mean age of 60 years (±11.46) and mean education of 11 years (±6.32).ResultsThe intraclass correlation coefficient (ICC) (inter-rater) was 0.954 (P<0.001 for a confidence interval (CI) of 95%=[0.932; 0.969]). Cultural equivalence was performed without the need for a second instrument application step.ConclusionAfter cross-cultural adaptation, the language of the resultant questionnaire was deemed easily understandable by the Brazilian population.

Highlights

  • Alzheimer’s disease (AD) is one of the most prominent public health issues

  • Permission to translate and adapt the instrument was granted by the researchers at the Centre for Research on Ageing, Health and Wellbeing (CRAHW) of the Australian National University (ANU)

  • The intra-class correlation coefficient of the ANU-ADRI was 0.954 (p

Read more

Summary

Introduction

Alzheimer’s disease (AD) is one of the most prominent public health issues. Around 8 million new cases of dementia are diagnosed each year, with AD being the most prevalent type.[1]. While a number of clinical or lifestyle-related factors such as a low educational level (less than 12 years), diabetes, hypertension in middle age, obesity in middle age, depression, dyslipidemia, and smoking are modifiable, biological or genetic factors such as age, gender, and apolipoprotein (APOE) ε4 genotypes are not.[6]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call